Parkin: Difference between revisions

Latest revision as of 20:51, 30 December 2024

Parkin

Parkin is a protein that in humans is encoded by the PARK2 gene. It is a component of a multiprotein E3 ubiquitin ligase complex that mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Mutations in the PARK2 gene are associated with Parkinson's disease, particularly a form known as autosomal recessive juvenile Parkinsonism.

Function[edit]

Parkin is involved in the ubiquitin-proteasome system, which is responsible for the degradation of proteins within the cell. It functions as an E3 ubiquitin ligase, which means it helps attach ubiquitin molecules to proteins, marking them for degradation by the proteasome. This process is crucial for maintaining cellular protein homeostasis and regulating various cellular processes.

Clinical Significance[edit]

Mutations in the PARK2 gene can lead to a loss of function of the parkin protein, resulting in the accumulation of damaged or misfolded proteins. This accumulation is toxic to neurons and is implicated in the pathogenesis of Parkinson's disease. Parkin mutations are one of the most common genetic causes of early-onset Parkinson's disease.

Parkinson's Disease[edit]

Parkinson's disease is a neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra of the brain. Symptoms include tremor, rigidity, bradykinesia, and postural instability. The role of parkin in the disease is linked to its function in protein degradation and mitochondrial quality control.

Research[edit]

Research into parkin and its role in Parkinson's disease is ongoing. Studies are focused on understanding how parkin mutations lead to neuronal death and exploring potential therapeutic strategies to enhance parkin function or compensate for its loss.

References[edit]

External Links[edit]

[Parkin Gene - Genetics Home Reference](https://ghr.nlm.nih.gov/gene/PARK2)
[Parkinson's Disease - MedlinePlus](https://medlineplus.gov/parkinsonsdisease.html)

   This article is a protein-related stub. You can help WikiMD by expanding it!

@@ Line 1: / Line 1: @@
-{{Infobox protein
+Parkin
-| name = Parkin
-| image = Parkin protein structure.png
-| caption = Structure of the Parkin protein
-| symbol = PARK2
-| HGNCid = 8609
-| OMIM = 602544
-| EntrezGene = 5071
-| RefSeq = NM_004562
-| UniProt = O60260
-}}
-'''Parkin''' is a protein that in humans is encoded by the '''PARK2''' gene. Parkin is a member of the RBR ubiquitin ligase family and plays a crucial role in the ubiquitin-proteasome system, which is responsible for the degradation of proteins within the cell. Mutations in the PARK2 gene are associated with a form of [[Parkinson's disease]] known as autosomal recessive juvenile Parkinsonism (AR-JP).
+'''Parkin''' is a protein that in humans is encoded by the '''PARK2''' gene. It is a component of a multiprotein E3 ubiquitin ligase complex that mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Mutations in the PARK2 gene are associated with [[Parkinson's disease]], particularly a form known as [[autosomal recessive juvenile Parkinsonism]].
-== Structure ==
-Parkin is a multi-domain protein that includes an N-terminal ubiquitin-like (Ubl) domain, a RING0 domain, two RING finger domains (RING1 and RING2), and an in-between RING (IBR) domain. The RING domains are critical for its function as an E3 ubiquitin ligase, facilitating the transfer of ubiquitin from an E2 enzyme to substrate proteins.
 == Function ==
-Parkin functions primarily as an E3 ubiquitin ligase, tagging damaged or misfolded proteins with ubiquitin molecules, marking them for degradation by the proteasome. This process is essential for maintaining cellular protein homeostasis and preventing the accumulation of toxic protein aggregates.
+Parkin is involved in the [[ubiquitin-proteasome system]], which is responsible for the degradation of proteins within the cell. It functions as an E3 ubiquitin ligase, which means it helps attach ubiquitin molecules to proteins, marking them for degradation by the [[proteasome]]. This process is crucial for maintaining cellular protein homeostasis and regulating various cellular processes.
-In addition to its role in protein degradation, Parkin is involved in the regulation of [[mitophagy]], a specialized form of autophagy that targets damaged mitochondria for degradation. Parkin translocates to the outer membrane of damaged mitochondria, where it ubiquitinates various mitochondrial surface proteins, signaling for their removal and degradation.
 == Clinical Significance ==
-Mutations in the PARK2 gene are one of the most common genetic causes of early-onset Parkinson's disease. These mutations can lead to a loss of Parkin's E3 ligase activity, resulting in the accumulation of damaged proteins and mitochondria, contributing to neuronal death and the development of Parkinsonian symptoms.
+Mutations in the PARK2 gene can lead to a loss of function of the parkin protein, resulting in the accumulation of damaged or misfolded proteins. This accumulation is toxic to neurons and is implicated in the pathogenesis of Parkinson's disease. Parkin mutations are one of the most common genetic causes of early-onset Parkinson's disease.
-Parkin mutations are typically inherited in an autosomal recessive manner, meaning that two copies of the mutated gene are required for the disease to manifest. Patients with PARK2 mutations often present with symptoms at a younger age compared to those with idiopathic Parkinson's disease.
+=== Parkinson's Disease ===
+Parkinson's disease is a neurodegenerative disorder characterized by the progressive loss of [[dopaminergic neurons]] in the [[substantia nigra]] of the brain. Symptoms include [[tremor]], [[rigidity]], [[bradykinesia]], and [[postural instability]]. The role of parkin in the disease is linked to its function in protein degradation and mitochondrial quality control.
-== Research and Therapeutic Approaches ==
+== Research ==
-Research into Parkin and its role in Parkinson's disease is ongoing, with efforts focused on understanding its precise molecular mechanisms and developing therapies that can enhance its function or compensate for its loss. Gene therapy, small molecules that enhance Parkin activity, and strategies to promote mitophagy are among the approaches being explored.
+Research into parkin and its role in Parkinson's disease is ongoing. Studies are focused on understanding how parkin mutations lead to neuronal death and exploring potential therapeutic strategies to enhance parkin function or compensate for its loss.
-== Also see ==
+== See Also ==
-* [[Parkinson's disease]]
 * [[Ubiquitin-proteasome system]]
-* [[Mitophagy]]
+* [[Neurodegenerative disorders]]
-* [[Autophagy]]
+* [[Genetic causes of Parkinson's disease]]
+== References ==
+<references/>
+== External Links ==
+* [Parkin Gene - Genetics Home Reference](https://ghr.nlm.nih.gov/gene/PARK2)
+* [Parkinson's Disease - MedlinePlus](https://medlineplus.gov/parkinsonsdisease.html)
 {{Protein-stub}}
@@ Line 40: / Line 32: @@
 [[Category:Proteins]]
 [[Category:Parkinson's disease]]
-[[Category:Ubiquitin ligases]]
+[[Category:Ubiquitin-proteasome system]]
+[[Category:Neurodegenerative disorders]]